Elicera Therapeutics AB's total assets for Q3 2025 were kr37.30M, a decrease of -8.82% from the previous quarter. SE:ELIC total liabilities were kr6.97M for the fiscal quarter, a -35.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.